Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacodynamics, Pharmacogenomics, and Preliminary Safety and Efficacy of Alemtuzumab Induction and Tacrolimus in Pediatric Intestinal Transplantation (IND # 100496)

NCT01208337 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT01208337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01208337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacodynamics, Pharmacogenomics, and Preliminary Safety and Efficacy of Alemtuzumab Induction and Tacrolimus in Pediatric Intestinal Transplantation (IND # 100496)
Lead sponsor
University of Pittsburgh
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2007
Completion date
November 30, 2014
Enrollment
23 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alemtuzumab, evidence of liver transplantation, rejection